The transition to reusable medical products in NHS hospitals in England and Wales: A theoretical domains framework informed qualitative study
- 1Department of Primary Care and Public Health, Brighton and Sussex Medical School, University of Brighton and University of Sussex, Brighton, United Kingdom
- 2The Centre for Sustainable Healthcare, Oxford, United Kingdom
- 3Department of Global Healthcare and Infection, Brighton and Sussex Medical School, University of Brighton and University of Sussex, Brighton, United Kingdom
Abstract
The National Health Service (NHS) faces environmental and financial pressures linked to the widespread use of single-use medical devices. Transitioning to reusable alternatives presents an opportunity to reduce waste, carbon emissions, and long-term costs while maintaining clinical outcomes. This study examined the readiness of NHS Trusts and Health Boards across England and Wales, United Kingdom, to adopt high-priority reusable products and identified barriers to implementation. Semi-structured qualitative interviews were conducted with stakeholders across clinical, procurement, and sustainability roles. Interviews were guided by the Theoretical Domains Framework (TDF) and supplemented with elements of the NASSS-CAT framework to explore behavioural, organisational, and systemic influences. Data were analysed using Framework Analysis and reported in accordance with COREQ guidelines. Thirteen NHS organisations participated. A common implementation structure emerged involving procurement teams, clinical leads, infection prevention and control (IPC), and decontamination services. Approval processes typically required clinical protocols, risk assessments, and senior leadership sign-off. Despite successful pilot initiatives, permanent adoption was often hindered by staff turnover, unclear governance, and financial hesitancy. Key barriers included the absence of a standardised implementation framework, limited leadership engagement, insufficient training, capital constraints, and inadequate infrastructure. Fragmented procurement systems and poor visibility of reusable options within NHS Supply Chain catalogues further impeded uptake. Risk perceptions within IPC teams varied widely across organisations. In conclusion, system-level leadership, governance, and infrastructure must be strengthened to support the transition to reusable medical products. A flexible, standardised implementation framework aligned with NHS quality improvement structures is needed. The role of patients and the public in this transition remains underexplored. Author summary: This study investigates how NHS Trusts and Health Boards in England and Wales are preparing to transition from single-use to reusable medical devices, addressing urgent environmental and financial challenges. Through qualitative interviews with stakeholders in clinical, procurement, and sustainability roles, the research identifies key behavioural, organisational, and systemic influences guiding the adoption of reusable products. Analysis revealed that implementation typically depends on multidisciplinary engagement—procurement teams, clinical leads, infection prevention, and decontamination services—requiring clinical protocols and senior leadership support. However, widespread adoption remains limited due to staff turnover, fragmented governance, capital constraints, and inconsistent risk perceptions regarding infection prevention. The lack of a standardised framework and incomplete visibility of reusable options within NHS procurement systems further complicate uptake. Strengthening system-level leadership, governance, and infrastructure, alongside a flexible yet standardised implementation framework, is essential to foster sustainable transformation. The study highlights the need for greater engagement with patients and the public in driving sustainable change in healthcare.
Related
- Barriers and facilitators to using an app-based tool for suicide safety planning in a psychiatric emergency department: A qualitative descriptive study using the Theoretical Domains Framework and COM-B model
- Health service staff and patients’ perceptions of the safety, quality, cost-effectiveness, environmental impact, benefits and challenges of disposable versus reusable endoscopes in upper gastrointestinal procedures: a qualitative study
- Understanding engagement with a deposit return scheme for reusable cups: A qualitative study on barriers and enablers of cup use and return through the COM-B Model
- Exploring multilevel determinants of nursing documentation quality in suicide care: A qualitative Study in Iranian hospitals
- Defining workload components and activity standards for human resources professionals in Iranian public hospitals: A WISN-based framework for strengthening non-clinical workforce planning
BibTeX
@article{llewellyn2026transition,
title = {{The transition to reusable medical products in NHS hospitals in England and Wales: A theoretical domains framework informed qualitative study}},
author = {Carrie D. Llewellyn and Anya Robinson and David Cameron and Rosie Hillson and Rachel McLean and Petar Tabakov and Frances Mortimer and Mahmood F. Bhutta},
journal = {PLOS Sustainability and Transformation},
year = {2026},
month = oct,
doi = {10.1371/journal.pstr.0000283},
url = {https://journals.plos.org/sustainabilitytransformation/article?id=10.1371/journal.pstr.0000283},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The transition to reusable medical products in NHS hospitals in England and Wales: A theoretical domains framework informed qualitative study
AU - Carrie D. Llewellyn
AU - Anya Robinson
AU - David Cameron
AU - Rosie Hillson
AU - Rachel McLean
AU - Petar Tabakov
AU - Frances Mortimer
AU - Mahmood F. Bhutta
PY - 2026
DA - 2026/10/05
JO - PLOS Sustainability and Transformation
DO - 10.1371/journal.pstr.0000283
UR - https://journals.plos.org/sustainabilitytransformation/article?id=10.1371/journal.pstr.0000283
AB - The National Health Service (NHS) faces environmental and financial pressures linked to the widespread use of single-use medical devices. Transitioning to reusable alternatives presents an opportunity to reduce waste, carbon emissions, and long-term costs while maintaining clinical outcomes. This study examined the readiness of NHS Trusts and Health Boards across England and Wales, United Kingdom, to adopt high-priority reusable products and identified barriers to implementation. Semi-structured qualitative interviews were conducted with stakeholders across clinical, procurement, and sustainability roles. Interviews were guided by the Theoretical Domains Framework (TDF) and supplemented with elements of the NASSS-CAT framework to explore behavioural, organisational, and systemic influences. Data were analysed using Framework Analysis and reported in accordance with COREQ guidelines. Thirteen NHS organisations participated. A common implementation structure emerged involving procurement teams, clinical leads, infection prevention and control (IPC), and decontamination services. Approval processes typically required clinical protocols, risk assessments, and senior leadership sign-off. Despite successful pilot initiatives, permanent adoption was often hindered by staff turnover, unclear governance, and financial hesitancy. Key barriers included the absence of a standardised implementation framework, limited leadership engagement, insufficient training, capital constraints, and inadequate infrastructure. Fragmented procurement systems and poor visibility of reusable options within NHS Supply Chain catalogues further impeded uptake. Risk perceptions within IPC teams varied widely across organisations. In conclusion, system-level leadership, governance, and infrastructure must be strengthened to support the transition to reusable medical products. A flexible, standardised implementation framework aligned with NHS quality improvement structures is needed. The role of patients and the public in this transition remains underexplored. Author summary: This study investigates how NHS Trusts and Health Boards in England and Wales are preparing to transition from single-use to reusable medical devices, addressing urgent environmental and financial challenges. Through qualitative interviews with stakeholders in clinical, procurement, and sustainability roles, the research identifies key behavioural, organisational, and systemic influences guiding the adoption of reusable products. Analysis revealed that implementation typically depends on multidisciplinary engagement—procurement teams, clinical leads, infection prevention, and decontamination services—requiring clinical protocols and senior leadership support. However, widespread adoption remains limited due to staff turnover, fragmented governance, capital constraints, and inconsistent risk perceptions regarding infection prevention. The lack of a standardised framework and incomplete visibility of reusable options within NHS procurement systems further complicate uptake. Strengthening system-level leadership, governance, and infrastructure, alongside a flexible yet standardised implementation framework, is essential to foster sustainable transformation. The study highlights the need for greater engagement with patients and the public in driving sustainable change in healthcare.
SN - 2767-3197
ER -